Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus

被引:10
|
作者
Youssef, Maha M.
El-Fayoumi, Dina
Sidky, Mohamed Karim
Hegazy, Ahmed I.
Marzouk, Huda
Eltanamly, Rasha M.
机构
[1] Cairo Univ, Fac Med, Dept Ophthalmol, Cairo, Egypt
[2] Cairo Univ, Fac Med, Dept Pediat Rheumatol, Cairo, Egypt
关键词
Children; Retinal toxicity; Microperimetry; Optical coherence tomography; Scanning laser ophthalmoscope; RETINOPATHY; CHLOROQUINE; RECOMMENDATIONS; SENSITIVITY; THERAPY;
D O I
10.1159/000461595
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate retinal sensitivity in children who are on hydroxychloroquine (HCQ) for systemic lupus erythematosus using microperimetry and compare the results with those of the Humphrey visual field (HVF) 10-2 and spectral-domain optical coherence tomography (SD-OCT). Procedure: A case-control cross-sectional study including 19 patients (less than 18 years old) on HCQ for at least 5 years. Controls were 21 normal children. Participants underwent a complete ophthalmic examination, then were investigated using HVF 10-2, SD-OCT, and microperimetry. Results: Ocular examination revealed no abnormalities. The overall mean microperimetry sensitivity of the patients (15.75 dB) was not significantly different from that of the controls (16.35 dB). The HVF 10-2 showed a significant difference in the mean deviation of the patients. Conclusions and Message: Microperimetry was not more revealing than HVF 10-2 and SDOCT. Larger studies are required to compare the diagnostic accuracy of screening modalities of retinal toxicity in children on HCQ. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:180 / 184
页数:5
相关论文
共 50 条
  • [41] Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematous
    Lee, Jae-Eun
    You, Seung-Hun
    Jung, Sun-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 401 - 402
  • [42] Juvenile systemic lupus erythematosus in Nigeria
    Adelowo, O. O.
    Olaosebikan, B. H.
    Animashaun, B. A.
    Akintayo, R. O.
    LUPUS, 2017, 26 (03) : 329 - 333
  • [43] Hydroxychloroquine Dose and the Risk of Systemic Lupus Erythematosus Flares
    Jorge, April
    Mancini, Christian
    Fu, Xiaoqing
    Ho, Gary
    Zhang, Yuqing
    Costenbader, Karen
    Choi, Hyon K.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3070 - 3072
  • [44] Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine
    Jorge Rodriguez-Hurtado, Francisco
    Antonio Saez-Moreno, Jose
    Manuel Rodriguez-Ferrer, Jose
    REUMATOLOGIA CLINICA, 2012, 8 (05): : 280 - 283
  • [45] Hydroxychloroquine and prediabetes in rheumatoid arthritis and systemic lupus erythematosus
    Penn, Sara Kaprove
    Vogt, Molly T.
    Kao, Amy H.
    Manzi, Susan
    Wasko, Mary Chester M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S325 - S326
  • [46] Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus
    Liu, Lucy H.
    Fevrier, Helene B.
    Goldfien, Robert
    Hemmerling, Anke
    Herrinton, Lisa J.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1309 - 1315
  • [47] Diplopia in a patient under hydroxychloroquine for systemic lupus erythematosus
    Sabbagh, M
    REVUE DU RHUMATISME, 1997, 64 (01): : 65 - 65
  • [48] Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus
    Tselios, Konstantinos
    Gladman, Dafna D.
    Harvey, Paula
    Mak, Susanna
    Chantal, Morel
    Butany, Jagdish
    Urowitz, Murray B.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (05) : 287 - 288
  • [49] Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus
    Tselios, Kostantinos
    Gladman, Dafna
    Harvey, Paula
    Mak, Susanna
    Yap, Kristy
    Morel, Chantal
    Butany, Jagdish
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1196 - 1196
  • [50] Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
    Dima, Alina
    Jurcut, Ciprian
    Chasset, Francois
    Felten, Renaud
    Arnaud, Laurent
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14